Literature DB >> 16204796

Effects of p53 inhibitor on survival and death of cells subjected to oxidative stress.

R P Strosznajder1, H Jesko, M Banasik, S Tanaka.   

Abstract

Our previous data indicate that ischemia and amyloid beta peptide (A beta) cause an oxidative damage to macromolecules. In the present study we investigated the role of p53 protein in cell survival and death after administration of A beta. The experiments were carried out on pheochromocytoma cells (PC-12) and cortical primary neurons in culture. The cortical neurons were exposed (48 h, 10 microM) to the action of a short A beta 25-35 neurotoxic fragment and the involvement of p53 was evaluated after addition of the p53 inhibitor pifithrin-alpha. Changes in cell morphology were evaluated by 4', 6-diamidino-2-phenylindole staining and the concentration-dependent effect of pifithrin-alpha on cells viability was determined. Additionally, we studied the effect of pifithrin-alpha on neuronal survival in vivo after a 5-min global brain ischemia followed by 7 days' reperfusion in gerbils. We found that A beta enhanced apoptotic cell death in cortical primary neurons. Pifithrin-alpha, at a 10 microM final concentration, protected the neuronal cells from the apoptotic death. However, at concentrations of 0.1 and 1 mM, the p53 inhibitor decreased PC-12 cells' viability in a dose-dependent manner. In in vivo experiments we did not observe any neuroprotection by pifithrin-alpha in the CA1 hippocampal layer, which suggests that its effects strongly depend on the duration and type of an ischemic insult. Our data indicate that pifithrin-alpha affects neuronal cells in a dual manner. It has a protective effect at a low concentration, but becomes neurotoxic at higher concentrations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204796

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  9 in total

Review 1.  Pathologies associated with the p53 response.

Authors:  Andrei V Gudkov; Elena A Komarova
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-07       Impact factor: 10.005

Review 2.  Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.

Authors:  Gerald Schmid; Joanna B Strosznajder; Józefa Wesierska-Gadek
Journal:  Mol Neurobiol       Date:  2006-08       Impact factor: 5.590

Review 3.  Mitochondrial damage: a target for new therapeutic horizons.

Authors:  Jean F Soustiel; Sarit Larisch
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

4.  p53 Small-molecule inhibitor enhances temozolomide cytotoxic activity against intracranial glioblastoma xenografts.

Authors:  Eduard B Dinca; Kan V Lu; Jann N Sarkaria; Russell O Pieper; Michael D Prados; Daphne A Haas-Kogan; Scott R Vandenberg; Mitchel S Berger; C David James
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

5.  MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma.

Authors:  Pedro M Costa; Ana L Cardoso; Clévio Nóbrega; Luís F Pereira de Almeida; Jeffrey N Bruce; Peter Canoll; Maria C Pedroso de Lima
Journal:  Hum Mol Genet       Date:  2012-11-30       Impact factor: 6.150

6.  Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress.

Authors:  Chinavenmeni S Velu; Suryakant K Niture; Catalin E Doneanu; Nagarajan Pattabiraman; Kalkunte S Srivenugopal
Journal:  Biochemistry       Date:  2007-06-08       Impact factor: 3.162

Review 7.  Molecular mechanisms and clinical implications of reversible protein S-glutathionylation.

Authors:  John J Mieyal; Molly M Gallogly; Suparna Qanungo; Elizabeth A Sabens; Melissa D Shelton
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

8.  Protective effect of Daming capsule against chronic cerebral ischemia.

Authors:  Xiaodan Song; Wenliang Zhu; Ran An; Yamei Li; Zhimin Du
Journal:  BMC Complement Altern Med       Date:  2015-05-14       Impact factor: 3.659

9.  Regenerative repair of Pifithrin-α in cerebral ischemia via VEGF dependent manner.

Authors:  Ping Zhang; Xuhui Lei; Ying Sun; Haitao Zhang; Liang Chang; Chenlong Li; Daming Liu; Nishant Bhatta; Zhiren Zhang; Chuanlu Jiang
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.